Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced (nonresectable) and metastatic biliary tumors: A randomized double-blinded placebo-controlled phase II trial.

Demols, Anne; Borbath, Ivan; Van den Eynde, Marc; Houbiers, Ghislain; Peeters, Marc; Maréchal, Raphael; Delaunoit, Thierry; Goeminne, Jean Charles.; Laurent, Stéphanie; Holbrechts, Stephane; Paesmans, Marianne; Van Laethem, Jean L.

doi:10.1200/jco.2019.37.4_suppl.345

Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced (nonresectable) and metastatic biliary tumors: A randomized double-blinded placebo-controlled phase II trial.

Demols, Anne

;

Borbath, Ivan

;

Van den Eynde, Marc

;

Houbiers, Ghislain

;

Van Laethem, Jean L.

;et.al.

(2019) ASCO-GI : American society of clinical oncology - Gastrointestinal Cancers Symposium — Location: (United States) San Francisco, CA (17.January.2019)

Files

2019_Demols_ASCO-GI_Abstract_345.pdf

Open Access
Adobe PDF
69.96 KB

Download

Details

Authors

Demols, Anne
Author
Borbath, IvanUCLouvain
Author
Van den Eynde, MarcUCLouvain
Author
Houbiers, Ghislain
Author
Van Laethem, Jean L.
Author

Affiliations

Citations

APA
Chicago
FWB

Demols, A., Borbath, I., Van den Eynde, M., Houbiers, G., Peeters, M., Maréchal, R., Delaunoit, T., Goeminne, J. Charles., Laurent, S., Holbrechts, S., Paesmans, M., & Van Laethem, J. L. (2019). Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced (nonresectable) and metastatic biliary tumors: A randomized double-blinded placebo-controlled phase II trial. Journal of Clinical Oncology, 37(Suppl 4), 345. https://doi.org/10.1200/jco.2019.37.4_suppl.345 (Original work published 2019)